Millions of Americans suffer from arthritis, and many reach for medication to ease their joint pain and inflammation.

The options might seem overwhelming, though. Here, the Arthritis Foundation offers some suggestions for meds that can be purchased at a local drug store or filled with a doctor's prescription, whether your pain is caused by normal wear and tear (osteoarthritis) or inflamma...

An anti-inflammatory drug that has been around for over 2,000 years might help delay a very modern problem: hip and knee replacements.

That's the suggestion of a new study finding that older adults who used the drug -- called colchicine -- were less likely to need hip or knee replacement surgery over the next two years, versus those given placebo pills.

The study, published May 30 i...

Man's aging best friend has a new treatment to dull osteoarthritis pain as the U.S. Food and Drug Administration (FDA) announced approval Friday of the first monoclonal antibody for dogs.

Called Librela, the bedinvetmab shot controls pain from the most common form of arthritis in dogs. Osteoarthritis (OA) affects about 25% of dogs during their lifetime.

In this condition, the cartil...

There are more than 100 types of arthritis and related conditions, and they affect at least 54 million adults and 300,000 children in the United States, according to the Arthritis Foundation.

Fortunately, there are also many medications, non-medication optio...

Arthritis is a common disease that causes pain and inflammation in different body joints, making it difficult to enjoy everyday tasks and physical activity.

Fortunately, there are many different medications for arthritis. Depending on what type of arthritis you have and its severity, an arthritis medication may help you manage pain and other symptoms. Here is a breakdown of the most comm...

Corticosteroid injections to relieve pain in patients with knee osteoarthritis could actually be setting them back.

Two new studies have discovered that, despite the temporary relief of symptoms, the injections were associated with continued progression of the disease.

On the other hand, patients injected with another symptom reliever, hyaluronic acid, saw decreased progression of t...

Over-the-counter pain relievers like aspirin, Aleve or ibuprofen don't do a thing to slow the progression of knee arthritis, and might even make things worse, a new study suggests.

Knee arthritis patients who regularly took nonsteroidal anti-inflammatory drugs (NSAIDs) wound up with worse knee inflammation and weakened cartilage, compared to a "control" group not taking the medications, <...

Long-term steroid use can reshape the structure of the brain, causing some parts to shrink and others to grow, a major new study reports.

People taking steroids -- even inhaled steroids -- appear to have less intact white matter structure in their brains compared with those not taking the drugs, brain scans reveal. White matter serves as the communication link between different regions of...

Physical therapy for knee arthritis tends to cost patients more out-of-pocket and involves a lot more hassle than a quick steroid shot to soothe an aching joint.

But in the long run, physical therapy is at least as cost-effective as steroid injections and is more likely to provide longer-term relief, a new study concludes.

"Even though maybe the initial costs of physical therapy are...

Two rheumatoid arthritis drugs show potential for lowering the risk of Parkinson's disease, new research shows.

Some previous studies have found that people with rheumatoid arthritis have a lower risk of Parkinson's, and it was suggested that a class of rheumatoid arthritis drugs called disease-modifying antirheumatic drugs (DMARDs) may play a role in that reduced risk.

To learn mor...

Allopurinol, a frequently used gout medication, does not appear to drive up the risk for dying among gout patients who also struggle with chronic kidney disease, new research shows.

The finding is based on an analysis of two decades worth of British health records. And it may put to rest recent concerns regarding a well-known drug that both gout patients and kidney disease patients have u...

"Ultra-low" doses of the drug rituximab may be enough to keep some patients' rheumatoid arthritis under control for several years, a new, preliminary study suggests.

Researchers found that among 118 patients, low doses of the drug were comparable to standard ones in controlling flare-ups for up to four years.

The findings, the researchers said, suggest that some patients can try low...

As doctors around the world come up against severe cases of COVID-19, some positive news has emerged: New research shows the rheumatoid arthritis drug baricitinib may help reduce hospitalized COVID patients' risk of death.

Current standard-of-care medications aren't enough, said study co-author Dr. E. Wesley Ely, a professor of medicine at Vanderbilt University Medical Center in Nashville...